Primary and secondary risk factors for coronary heart disease: their role in prevention
Wilhelmsen, L.
Medical Journal of Malaysia 31(4): 296-301
1977
ISSN/ISBN: 0300-5283 PMID: 927236 Document Number: 119510
Document emailed within 1 workday
Related Documents
Stamler, J. 1973: Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 54-59Meinertz, T.; Heitzer, T. 2002: Primary and secondary prevention of coronary heart disease: smoking Zeitschrift für Kardiologie 91 Suppl. 2: 3-11
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
Judelson, D.R. 1994: Coronary heart disease in women: risk factors and prevention Journal of the American Medical Women's Association 49(6): 186-91 197
Leclerc, K.M. 1992: The role of exercise in reducing coronary heart disease and associated risk factors Journal of the Oklahoma State Medical Association 85(6): 283-290
Wilhelmsen, L. 1982: Secondary prevention of coronary heart disease. A review Cor et Vasa 24(4): 216-227
Assmann, G. 1999: Secondary coronary heart disease prevention by red wine? Der Internist 40(9): 982
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Novák, J. 1988: The program for primary prevention and secondary prevention of ischemic coronary disease and research at the Laboratory of Human Energy Resources of the University of Wyoming in Laramie Casopis Lekaru Ceskych 127(37-38): 1190-1192
Ning, X.-h.; Xiang, X.-p.; Lu, N.; Zhang, Y.-x.; Wang, W.-j.; Liu, Y.; Zhou, Z. 2008: Relation of risk factors to coronary artery stenosis severity in coronary atherosclerotic heart disease Zhonghua Yi Xue Za Zhi 88(18): 1267-1269
Agarwal, A.K.; Singla, S.; Singla, S.; Singla, R.; Lal, A.; Wardhan, H.; Yadav, R. 2009: Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease Journal of the Association of Physicians of India 57(1): 135-142
Lindbloom, E.J.; Eaton, L.J. 2002: Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease Journal of Family Practice 51(9): 789
Villanueva, J.A. 2004: Cerebrovascular disease risk factors and secondary prevention Anales de Medicina Interna 21(4): 159-160
McKenna, C.J.; Sugrue, D.D. 1995: Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives Irish Medical Journal 88(6): 191
Arnheim, K. 2000: Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids MMW Fortschritte der Medizin 142(24): 18
Jost, S.; Lichtlen, P.R. 1995: Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease Zeitschrift für Kardiologie 84(8): 577-595
Ringstad, J.; Jacobsen, B.K.; Thomassen, Y. 1987: The Tromsø Heart Study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease Journal of Trace Elements and Electrolytes in Health and Disease 1(1): 27-31
Sattar, N.; Welsh, P.; Sarwar, N.; Danesh, J.; Di Angelantonio, E.; Gudnason, V.; Davey Smith, G.; Ebrahim, S.; Lawlor, D.A. 2010: NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study Atherosclerosis 209(1): 295-299
Enbergs, A.; Liese, A.; Heimbach, M.; Kerber, S.; Scheld, H.H.; Breithardt, G.; Kleine-Katthöfer, P.; Keil, U. 1997: Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region Zeitschrift für Kardiologie 86(4): 284-291
Gryglik, J. 1979: Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease Polski Tygodnik Lekarski 34(13): 509-511